Anavex Life Sciences Corp (AVXL)
Healthcare
Biotechnology
2.80 $
+1.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Anavex Life Sciences Corp (AVXL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.9% of the shares are freely tradable; institutional investors hold 43.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
43.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
3.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
96.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
19.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
93Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.21 | 7,609,618 | +1.1 | 03/31/2026 |
| Vanguard Group Inc | 5.43 | 5,028,534 | -1.5 | 12/31/2025 |
| State Street Corp | 4.87 | 4,512,028 | +2.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.17 | 3,863,950 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 3.50 | 3,247,888 | +96.4 | 03/31/2026 |
| Geode Capital Management, LLC | 2.36 | 2,188,275 | +8.2 | 03/31/2026 |
| Two Sigma Advisers, LLC | 1.31 | 1,209,570 | +59.5 | 12/31/2025 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.19 | 2,955,659 | -0.6 | 05/31/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.95 | 2,731,053 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 2.24 | 2,072,888 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.